Annual Report

The Guidelines Group remains active, and continues its work in the development of guidelines and position statements.

Current live publications produced by the Group include:

• Guidelines on the diagnosis, investigation and initial treatment of myeloma 2021
• Use of imaging in the management of patients with multiple myeloma. July 2017
• Guidelines for screening and management of late and long-term consequences of myeloma and its treatment. January 2017
• AL amyloid guidelines (diagnosis and management)  October 2014 
  
  

Current work plans

The UKMS Guidelines Group has been working on a guideline for the treatment of relapsed and refractory patients, and good progress has been made towards publication this year.

UKMS Good Practice Papers (GPPs) on the investigation and management of monoclonal gammopathy of undetermined significance (MGUS), a separate GPP on the investigation and management of monoclonal gammopathy of renal significance (MGRS) and a GPP/guideline on imaging in multiple myeloma are also at various stages of development. Work will start soon on a GPP on the managment of smouldering myeloma.  

Dr Simon Stern

Chair of UKMS Guidelines Group

April 2023